A pharmacy transfer in Paris is not managed the same way as in the provinces. The density of the pharmacy network, real estate constraints, and the specifics of the ARS Île-de-France require a higher level of preparation than in most other regions. Here, we detail the real points of friction that cause files to fail or be delayed.
Mastery of the premises and Parisian real estate constraints
The premises are the most common bottleneck in a Parisian file. The ARS requires a solid proof of control over the projected premises even before processing the application. A lease signed under a suspensive condition of obtaining the transfer authorization is the standard arrangement, but in Paris, commercial landlords rarely agree to hold a premises for several months.
We recommend negotiating a lease promise with a completion timeline aligned with the regulatory schedule. The official processing time is four months from the receipt, plus an additional period before the authorization becomes enforceable. The lease must cover this entire window, or you risk losing the premises even before the end of the procedure.
Compliance of the premises with accessibility standards, commercial urban planning rules, and any easements related to Parisian co-ownerships further complicate matters. An early technical diagnosis avoids the need to assemble a complete administrative file for a premises that will turn out to be unsuitable.
Each step of a pharmacy transfer file in Paris should be anticipated in parallel, rather than sequentially, precisely because real estate and administrative timelines intertwine.
ARS Île-de-France file: dematerialization and critical documents
The ARS Île-de-France has a dedicated digital form for transfer requests, which speeds up the submission but does not simplify the substance. Dematerialization imposes strict formatting of supporting documents. A poorly scanned document or a file that is too large can lead to a technical rejection without substantive review.
The file must include the following elements:
- The identity and qualifications of each pharmacist holder or associate, including diplomas and registration with the Order
- The exact location of the current pharmacy and the projected premises, with elements justifying the applicant’s rights to the latter (lease promise, compromise, title of ownership)
- Data to verify compliance with demographic conditions and drug supply in the destination neighborhood
- If applicable, elements related to the continuity of emergency and on-call service
The classic trap in Paris concerns the demographic conditions in the central arrondissements. The pharmacy density is already high there, and the ARS applies the thresholds of the Public Health Code rigorously. Before looking for a premises, we advise checking the pharmacy mapping with the regional Order to identify areas where a transfer has a realistic chance of success.
Processing time and administrative silence regime
A common mistake is to believe that the absence of a response from the ARS equates to acceptance. The silence of the administration equates to rejection in the matter of pharmacy transfer, not tacit approval. This regime, inverted compared to common law, regularly surprises project holders who think their file is validated when it has been implicitly refused.
The four-month processing period begins from the issuance of the completeness receipt, not from the date of submission. If the file is incomplete, the ARS requests additional information, and the timeline resets. In Paris, back-and-forth can easily add several weeks.
Non-immediate effect of the authorization
Even after obtaining the authorization, the transfer cannot be executed immediately. An additional delay applies before the decision becomes enforceable, particularly to allow for possible appeals from third parties. Confusing authorization with execution remains the most costly scheduling error, especially when a lease is already in place for the new premises.
Communication around the transfer: what the March 2026 decree changes
Since March 6, 2026, the advertising of a pharmacy can be done on any medium, in compliance with the Public Health Code. This change concretely modifies how a pharmacist can inform their clientele about a move.
Before this decree, communication was very regulated and practically limited to in-pharmacy displays and word-of-mouth. Now, it is possible to use digital media (website, social networks, emails) to announce the transfer, as long as it does not fall into comparative advertising or superiority claims.
For a Parisian transfer, where the clientele is often split between workplace and residence, this new latitude allows for limiting the loss of clientele related to the change of address. We observe that pharmacies that prepare a structured communication plan ahead of the move retain a significantly larger share of their revenue during the initial months.
The pharmacy transfer in Paris remains an operation where the administrative timeline, real estate negotiation, and commercial strategy must advance simultaneously. A technically flawless file submitted for a secured premises in a demographically eligible area is the only configuration that truly secures the project.
